Меню
Набор скоро начнётся NCT07622134

Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD)

Без фазы С лечением Chronic Kidney Diseases Polypharmacy Health Literacy

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Health Literacy Promotion Program (HLP-CKD).
Кому может быть актуально
Состояния в реестре: Chronic Kidney Diseases, Polypharmacy, Health Literacy. Базовые параметры: 55 лет — 74 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Таиланд
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Effectiveness of the Health Literacy Promotion Program to Prevent Chronic Kidney Disease of Patients Who Use Polypharmacy

Обзор

This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.

Подробное описание

Background: Patients with polypharmacy are at a higher risk of drug-induced kidney injury. Enhancing health literacy is a key strategy to empower these patients to engage in protective health behaviors.

Objectives: 1) To compare health literacy scores before and after participating in the program. 2) To compare CKD prevention behaviors between the experimental and control groups.

Methodology: This is a quasi-experimental study with a pre-test/post-test design.

Experimental Group: Receives the "Health Literacy Promotion Program," which includes educational sessions, skill-building for medication management, and follow-up support.

Control Group: Receives routine nursing care and standard health education. Intervention Details: The program focuses on 6 aspects of health literacy: access, understanding, communication, questioning, decision-making, and practice.

Data Collection: Data will be collected using validated questionnaires for health literacy and CKD prevention behavior at baseline and after the intervention (e.g., at week 12).

Analysis: Descriptive statistics and t-tests (Independent and Paired) will be used to evaluate the program's effectiveness.

Вмешательства

  • Поведенческое Health Literacy Promotion Program (HLP-CKD)
    An 8-week program consisting of educational sessions, skill-building for medication management, and follow-up support to prevent chronic kidney disease.

Первичные конечные точки

  • Health Literacy Levels [Срок оценки: Baseline, 8 weeks (immediately after intervention), and 12 weeks (follow-up).]
  • CKD Prevention Behaviors [Срок оценки: Baseline, 8 weeks, and 12 weeks.]
Вторичные конечные точки (3)
  • Estimated Glomerular Filtration Rate (eGFR) [Срок оценки: Baseline and 12 weeks (follow-up)]
  • Serum Creatinine [Срок оценки: Baseline and 12 weeks (follow-up)]
  • Urine Albumin-to-Creatinine Ratio (UACR) [Срок оценки: Baseline and 12 weeks (follow-up).]

Критерии участия

Критерии включения

  • Patients aged 55-74 years diagnosed with non-communicable diseases.
  • Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
  • Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
  • Able to communicate, read, and write in Thai.
  • Willing to participate in the 8-week program and follow-up assessments.

Критерии исключения

  • Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
  • Having severe cognitive impairment or psychiatric disorders that prevent participation.
  • Having severe complications or being in an unstable clinical condition.
  • Planning to move out of the study area during the 12-week study period.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Профилактика

Центры проведения

Таиланд · 1 центр
  • Health Promoting Hospital — Nakhon Pathom

Идентификаторы

NCT: NCT07622134 · 009/2026 · 012/2024

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗